Kee Song Bio-Technology Holdings Limited announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 2,835.038 million compared to TWD 2,480.922 million a year ago. Net operating loss was TWD 81.406 million compared to operating income of TWD 94.243 million a year ago. Net loss was TWD 149.192 million compared to net income of TWD 46.336 million a year ago. Basic loss per share was TWD 4.05 compared to basic earnings per share of TWD 1.26 a year ago. Diluted loss per share was TWD 4.05 compared to diluted earnings per share of TWD 1.23 a year ago.